Male contraception: narrative review of ongoing research

BackgroundSince the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However,...

Full description

Saved in:
Bibliographic Details
Published inBasic and clinical andrology Vol. 33; no. 1; pp. 1 - 12
Main Authors Louwagie, Eli J., Quinn, Garrett F.L., Pond, Kristi L., Hansen, Keith A.
Format Journal Article
LanguageEnglish
Published London BioMed Central 09.11.2023
BMC
Subjects
Androgens
Birth control
Clinical trials
Endocrinology
Estrogens
Hormones
Male contraception
Males
Progestin
R&D
Reproductive health
Research & development
Review
Sperm
Spermatogenesis
Vasectomy
Womens health
United States > US
Online AccessGet full text

Cover

Abstract BackgroundSince the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development.ResultsAs of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development.ConclusionsThere exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
AbstractList Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development.BACKGROUNDSince the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development.As of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development.RESULTSAs of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development.There exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.CONCLUSIONSThere exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
Abstract Background Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development. Results As of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development. Conclusions There exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
BackgroundSince the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later, this is still the case as the only practical, effective contraceptive options available to men are condoms and vasectomy. However, there are now a variety of promising hormonal and non-hormonal male contraceptive options being studied. The purpose of this narrative review is to provide clinicians and laypeople with focused, up-to-date descriptions of novel strategies and targets for male contraception. We include a cautiously optimistic discussion of benefits and potential drawbacks, highlighting several methods in preclinical and clinical stages of development.ResultsAs of June 2023, two hormonal male contraceptive methods are undergoing phase II clinical trials for safety and efficacy. A large-scale, international phase IIb trial investigating efficacy of transdermal segesterone acetate (Nestorone) plus testosterone gel has enrolled over 460 couples with completion estimated for late 2024. A second hormonal method, dimethandrolone undecanoate, is in two clinical trials focusing on safety, pharmacodynamics, suppression of spermatogenesis and hormones; the first of these two is estimated for completion in December 2024. There are also several non-hormonal methods with strong potential in preclinical stages of development.ConclusionsThere exist several hurdles to novel male contraception. Therapeutic development takes decades of time, meticulous work, and financial investment, but with so many strong candidates it is our hope that there will soon be several safe, effective, and reversible contraceptive options available to male patients.
ArticleNumber 30
Author Louwagie, Eli J.
Pond, Kristi L.
Hansen, Keith A.
Quinn, Garrett F.L.
Author_xml – sequence: 1
  givenname: Eli J.
  orcidid: 0000-0001-8741-2240
  surname: Louwagie
  fullname: Louwagie, Eli J.
– sequence: 2
  givenname: Garrett F.L.
  surname: Quinn
  fullname: Quinn, Garrett F.L.
– sequence: 3
  givenname: Kristi L.
  surname: Pond
  fullname: Pond, Kristi L.
– sequence: 4
  givenname: Keith A.
  surname: Hansen
  fullname: Hansen, Keith A.
BookMark eNp9kU9v1DAQxS1UREvpF-AUiQuXwIztJDYXhCr-VCriAmfLsSdbr7L2YmcX0U-Pt1sk2gO-2Bq_-T2P33N2ElMkxl4ivEFU_duCvEdogYsWgINsb5-wMw4dthI1nPxzPmUXpayhLq0FKHjGTsWgJahenDH11c7UuBSXbB1tl5DiuybanO0S9tRk2gf61aSpSXGVQlzVSiGb3c0L9nSyc6GL-_2c_fj08fvll_b62-eryw_XreskLq1XdgBQjjo5Ilg7kvVI3sqO-5E7QV460KMjommUEyrru07KQfTkuCAtztnVkeuTXZttDhubf5tkg7krpLwyNi_BzWRwmpDQqbGHXspuUsOkqz-hptF50VfW-yNruxs35B0dpp4fQB_exHBjVmlvEHohgWMlvL4n5PRzR2Uxm1AczbONlHbFcKUUiI7jwezVI-k67XKsf1VVGqDnHIeqUkeVy6mUTJNxYbGHGOoDwlydzSFuc4zb1LjNXdzmtrbyR61_B_lP0x_b7q7f
CitedBy_id crossref_primary_10_1016_j_contraception_2024_110782
crossref_primary_10_3390_jcm14072188
crossref_primary_10_1016_j_jhazmat_2024_137001
crossref_primary_10_3389_fvets_2024_1409386
Cites_doi 10.1016/j.pep.2016.01.009
10.1210/jc.2002-020447
10.1016/j.jsbmb.2007.11.009
10.1210/en.2015-1675
10.1111/andr.13025
10.1016/j.contraception.2008.05.007
10.1042/bst0391447
10.1111/j.1365-2605.1992.tb01138.x
10.3389/fcell.2021.686461
10.1016/j.socscimed.2018.01.040
10.1002/mrd.23539
10.1210/jc.2016-2141
10.1016/j.contraception.2023.110064
10.2164/jandrol.109.009365
10.1363/psrh.12017
10.1016/j.contraception.2006.12.001
10.1001/jamapsychiatry.2016.2387
10.1124/dmd.122.001041
10.1210/jcem.75.5.1430094
10.1111/andr.12303
10.1210/en.2005-1524
10.1016/j.febslet.2010.02.005
10.2164/jandrol.109.008466
10.1002/cmdc.201700503
10.1371/journal.pone.0006844
10.1210/en.2016-1426
10.3389/fcell.2023.1134051
10.1111/j.1365-2605.1992.tb01139.x
10.1210/jc.2012-1384
10.1074/jbc.M114.607556
10.1021/ml300365k
10.3390/pharmacy8030156
10.1111/jmwh.12992
10.1016/0041-008x(61)90002-3
10.1111/andr.12603
10.1016/s2214-109x(20)30315-6
10.1016/j.fertnstert.2021.03.047
10.1363/4410712
10.1093/humrep/deh574
10.1016/j.contraception.2014.05.013
10.1210/clinem/dgaa761
10.1038/s41467-023-36119-6
10.1783/147118909788707986
10.1074/jbc.273.6.3509
10.4103/ijmr.IJMR_635_18
10.1016/j.mce.2020.110951
10.1210/jc.2007-2768
10.3390/nu14061293
10.1016/j.contraception.2010.04.004
10.1007/s43032-020-00408-y
10.1210/jc.2008-1846
10.1093/molehr/gaab066
10.1111/bph.14355
10.1016/j.ydbio.2008.03.047
10.1073/pnas.2221758120
10.1080/00224499.2017.1311834
10.1111/j.2047-2927.2013.00135.x
10.1016/j.contraception.2019.07.139
10.1016/S0015-0282(16)58221-1
10.1016/j.contraception.2023.109956
10.1016/B978-0-323-85718-5.00013-3
10.1046/j.1365-2265.2000.01097.x
10.18773/austprescr.2022.025
10.1210/jc.2008-2604
10.2105/ajph.2013.301416
10.1371/journal.pone.0195953
10.1210/jc.2002-022043
10.1016/j.beem.2010.08.006
10.1016/j.bmcl.2020.126958
10.1016/S0010-7824(00)00139-6
10.1016/s2214-109x(19)30265-7
10.1021/acs.jmedchem.2c00453
10.1210/jc.2004-1852
10.1021/acs.jmedchem.6b01336
10.1186/s12610-017-0048-9
10.1016/s0010-7824(97)00142-x
10.1210/clinem/dgaa032
10.1126/science.1099743
10.1021/acs.jmedchem.2c01133
10.1038/nrm.2016.143
10.2164/jandrol.107.002683
10.1210/jcem.81.11.8923869
10.1210/jc.2003-030107
10.1093/biolre/ioaa122
10.1038/nchembio.2151
10.2164/jandrol.110.010751
10.3389/fendo.2022.891589
10.2164/jandrol.110.010371
10.1002/cmdc.202000499
10.1210/en.2006-1487
10.1210/clinem/dgab034
10.25259/JRHM_8_2022
10.1073/pnas.1100240108
10.1016/0140-6736(90)92416-F
10.1016/0010-7824(78)90045-8
10.1016/j.contraception.2007.08.006
10.1016/j.fertnstert.2008.07.1751
10.1073/pnas.2021102118
10.1177/26334941221138323
10.1001/jamapsychiatry.2019.2838
10.1111/j.2047-2927.2014.00216.x
10.1073/pnas.2212338120
10.1210/en.2010-0941
10.1210/jcem.77.2.8345047
10.1016/j.cell.2012.06.045
10.1093/biolre/ioaa064
10.1210/jcem.87.2.8218
10.1016/j.jsbmb.2010.06.009
10.1038/s41573-019-0030-7
10.1186/s12610-017-0051-1
10.1242/dev.004481
10.1210/jc.2018-01452
10.1093/molehr/gaab054
10.1021/acs.jmedchem.7b01666
10.1210/jc.2018-01528
10.1016/s0039-128x(00)00119-7
10.1210/jcem-73-6-1360
10.1093/humrep/15.3.672
10.1128/mcb.25.10.4250-4261.2005
10.1530/rep-11-0171
10.1186/s12610-016-0033-8
ContentType Journal Article
Copyright 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. Société d’Andrologie de Langue Française and BioMed Central Ltd.
Société d’Andrologie de Langue Française and BioMed Central Ltd. 2023
Copyright_xml – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. Société d’Andrologie de Langue Française and BioMed Central Ltd.
– notice: Société d’Andrologie de Langue Française and BioMed Central Ltd. 2023
DBID AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12610-023-00204-z
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central Database Suite (ProQuest)
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2051-4190
EndPage 12
ExternalDocumentID oai_doaj_org_article_1ff1e1c8b606445f87f9d8ae19ebcd36
PMC10634021
10_1186_s12610_023_00204_z
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID 0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ADBBV
ADRAZ
ADUKV
AFKRA
AFPKN
AHBYD
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
EBLON
EBS
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
IHW
ITC
KQ8
M48
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
ROL
RPM
RSV
SOJ
UKHRP
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c541t-d8a7008ce54b10aabead1eda452db2c3ed4c09bceeefb4f18ad5544736ec23e93
IEDL.DBID DOA
ISSN 2051-4190
IngestDate Wed Aug 27 01:32:57 EDT 2025
Thu Aug 21 18:36:30 EDT 2025
Fri Jul 11 03:46:20 EDT 2025
Mon Jun 30 14:44:41 EDT 2025
Tue Jul 01 01:46:38 EDT 2025
Thu Apr 24 23:02:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-d8a7008ce54b10aabead1eda452db2c3ed4c09bceeefb4f18ad5544736ec23e93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8741-2240
OpenAccessLink https://doaj.org/article/1ff1e1c8b606445f87f9d8ae19ebcd36
PMID 37940863
PQID 2890062217
PQPubID 2040167
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_1ff1e1c8b606445f87f9d8ae19ebcd36
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10634021
proquest_miscellaneous_2888035216
proquest_journals_2890062217
crossref_citationtrail_10_1186_s12610_023_00204_z
crossref_primary_10_1186_s12610_023_00204_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-09
PublicationDateYYYYMMDD 2023-11-09
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-09
  day: 09
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Basic and clinical andrology
PublicationYear 2023
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References L Curci (204_CR110) 2021; 9
E Shang (204_CR83) 2007; 134
204_CR55
204_CR58
DJ Handelsman (204_CR22) 2000; 15
204_CR53
SS Chung (204_CR77) 2016; 157
JE Long (204_CR128) 2021; 106
A Kamischke (204_CR25) 2000; 53
AE de Wit (204_CR70) 2020; 77
M Lyon (204_CR117) 2023; 120
MG O’Rand (204_CR99) 2018; 13
204_CR100
WHO Task Force on Methods for the Regulation of Male Fertility (204_CR30) 1996; 65
204_CR101
NA Spiridonov (204_CR92) 2005; 25
Y-Q Gu (204_CR32) 2003; 88
MG O’Rand (204_CR98) 2004; 306
J Bearak (204_CR9) 2020; 8
L Turner (204_CR23) 2003; 88
A Thirumalai (204_CR43) 2019; 104
204_CR41
204_CR42
IS Fraser (204_CR52) 2007; 76
JC Chávez (204_CR112) 2014; 289
D Waller (204_CR122) 2017; 27
JE Hawkinson (204_CR95) 2017; 12
B Vaughan (204_CR8) 2008; 78
A Thirumalai (204_CR127) 2021; 115
BJ Attardi (204_CR60) 2006; 147
SC Zhao (204_CR124) 1992; 15
K Heinemann (204_CR11) 2005; 20
AM Salicioni (204_CR89) 2020; 103
Z Tan (204_CR113) 2023; 120
204_CR74
SS Chung (204_CR76) 2011; 152
BJ Attardi (204_CR68) 2010; 122
E Mu (204_CR69) 2022; 45
JK Amory (204_CR78) 2011; 32
A Kamischke (204_CR26) 2002; 87
R Rahban (204_CR106) 2020; 518
BJ Attardi (204_CR65) 2011; 32
XH Zeng (204_CR116) 2011; 108
DJ Handelsman (204_CR24) 1996; 81
MY Roth (204_CR59) 2014; 90
204_CR66
PY Liu (204_CR56) 2008; 93
A Rennhack (204_CR108) 2018; 175
BJ Attardi (204_CR61) 2008; 110
SS Chung (204_CR79) 2013; 4
RI McLachlan (204_CR31) 2000; 62
X Guan (204_CR88) 2022; 65
EJ Carlson (204_CR111) 2022; 17
SA Hild (204_CR64) 2007; 148
MM Matzuk (204_CR84) 2012; 150
AM Ayoub (204_CR85) 2017; 60
M Miller (204_CR102) 2022; 65
SK Guha (204_CR118) 1997; 56
MJ Walton (204_CR18) 2007; 28
204_CR16
NK Lohiya (204_CR120) 2022; 3
204_CR14
CG Heller (204_CR75) 1961; 3
T Fujisawa (204_CR81) 2017; 18
DF Archer (204_CR54) 2019; 7
H Zhang (204_CR93) 2010; 31
R Sitruk-Ware (204_CR51) 2010; 82
R Ayoub (204_CR44) 2017; 5
L Ramos-Espiritu (204_CR104) 2016; 12
R García-Becerra (204_CR19) 2012; 143
BD Anawalt (204_CR38) 2019; 7
A Wisniewski (204_CR82) 2020; 30
K Kimport (204_CR5) 2018; 201
C Ritagliati (204_CR105) 2023; 11
Y Gu (204_CR33) 2009; 94
JJ Frost (204_CR72) 2012; 44
F Yuen (204_CR46) 2021; 9
A Sundaram (204_CR7) 2017; 49
204_CR87
M Schreiber (204_CR114) 1998; 273
N Kumar (204_CR50) 2017; 158
MG O’Rand (204_CR97) 2011; 39
CE Klein (204_CR15) 2003
ST Page (204_CR3) 2022; 13
V Mahabadi (204_CR40) 2009; 94
SN Pavlou (204_CR20) 1991; 73
E Nieschlag (204_CR35) 1978; 18
MAA Noman (204_CR73) 2020; 103
DJ Handelsman (204_CR34) 1992; 75
C Myers (204_CR1) 2019; 100
LB Finer (204_CR10) 2014; 104
204_CR37
S von Eckardstein (204_CR17) 2003; 88
M Balbach (204_CR103) 2023; 14
N Kumar (204_CR49) 2000; 65
MC Meriggiola (204_CR27) 2005; 90
AE Carlson (204_CR109) 2009; 4
204_CR36
A Alspaugh (204_CR6) 2020; 65
N Ilani (204_CR39) 2012; 97
K Kimport (204_CR2) 2023; 120
SA Hild (204_CR63) 2010; 31
A Colagross-Schouten (204_CR123) 2017; 27
CA Service (204_CR129) 2023; 17
MY Roth (204_CR57) 2013; 1
204_CR126
S Nayyab (204_CR91) 2021; 88
CM Santi (204_CR115) 2010; 584
SC Zhao (204_CR125) 1992; 15
B Xu (204_CR90) 2008; 319
J Shetty (204_CR94) 2016; 121
CJ Bagatell (204_CR21) 1993; 77
HM Behre (204_CR28) 2016; 101
R Dcunha (204_CR96) 2022; 29
RS Sharma (204_CR119) 2019; 150
H Li (204_CR107) 2009; 92
F Yuen (204_CR47) 2020; 105
S Sharma (204_CR62) 2022; 50
AG Cochran (204_CR80) 2019; 18
WHO Task Force on Methods for the Regulation of Male Fertility (204_CR29) 1990; 336
C Krausz (204_CR13) 2011; 25
P Surampudi (204_CR45) 2014; 2
A Thirumalai (204_CR67) 2021; 106
K Kimport (204_CR4) 2018; 55
J Eberhardt (204_CR12) 2009; 35
CW Skovlund (204_CR71) 2016; 73
RP Law (204_CR86) 2018; 61
S Wu (204_CR48) 2019; 104
D Waller (204_CR121) 2016; 26
References_xml – volume: 121
  start-page: 88
  year: 2016
  ident: 204_CR94
  publication-title: Protein Expr Purif
  doi: 10.1016/j.pep.2016.01.009
– volume: 88
  start-page: 562
  issue: 2
  year: 2003
  ident: 204_CR32
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-020447
– volume: 110
  start-page: 214
  issue: 3–5
  year: 2008
  ident: 204_CR61
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2007.11.009
– volume: 157
  start-page: 1601
  issue: 4
  year: 2016
  ident: 204_CR77
  publication-title: Endocrinology
  doi: 10.1210/en.2015-1675
– volume: 9
  start-page: 1526
  issue: 5
  year: 2021
  ident: 204_CR46
  publication-title: Andrology
  doi: 10.1111/andr.13025
– volume: 78
  start-page: 271
  issue: 4
  year: 2008
  ident: 204_CR8
  publication-title: Contraception
  doi: 10.1016/j.contraception.2008.05.007
– volume: 39
  start-page: 1447
  issue: 5
  year: 2011
  ident: 204_CR97
  publication-title: Biochem Soc Trans
  doi: 10.1042/bst0391447
– volume: 15
  start-page: 460
  issue: 6
  year: 1992
  ident: 204_CR124
  publication-title: Int J Androl
  doi: 10.1111/j.1365-2605.1992.tb01138.x
– volume: 9
  start-page: 686461
  year: 2021
  ident: 204_CR110
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2021.686461
– volume: 201
  start-page: 44
  year: 2018
  ident: 204_CR5
  publication-title: Soc Sci Med
  doi: 10.1016/j.socscimed.2018.01.040
– volume: 88
  start-page: 718
  issue: 11
  year: 2021
  ident: 204_CR91
  publication-title: Mol Reprod Dev
  doi: 10.1002/mrd.23539
– volume: 101
  start-page: 4779
  issue: 12
  year: 2016
  ident: 204_CR28
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2016-2141
– ident: 204_CR66
– ident: 204_CR37
  doi: 10.1016/j.contraception.2023.110064
– volume: 31
  start-page: 472
  issue: 5
  year: 2010
  ident: 204_CR63
  publication-title: J Androl
  doi: 10.2164/jandrol.109.009365
– volume: 49
  start-page: 7
  issue: 1
  year: 2017
  ident: 204_CR7
  publication-title: Perspect Sex Reprod Health
  doi: 10.1363/psrh.12017
– ident: 204_CR14
  doi: 10.1016/j.contraception.2006.12.001
– ident: 204_CR41
– volume: 73
  start-page: 1154
  issue: 11
  year: 2016
  ident: 204_CR71
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2016.2387
– volume: 50
  start-page: 1493
  issue: 12
  year: 2022
  ident: 204_CR62
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.122.001041
– volume: 75
  start-page: 1326
  issue: 5
  year: 1992
  ident: 204_CR34
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.75.5.1430094
– volume: 5
  start-page: 278
  issue: 2
  year: 2017
  ident: 204_CR44
  publication-title: Andrology
  doi: 10.1111/andr.12303
– ident: 204_CR126
– volume: 147
  start-page: 3016
  issue: 6
  year: 2006
  ident: 204_CR60
  publication-title: Endocrinology
  doi: 10.1210/en.2005-1524
– volume: 584
  start-page: 1041
  issue: 5
  year: 2010
  ident: 204_CR115
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2010.02.005
– volume: 31
  start-page: 388
  issue: 4
  year: 2010
  ident: 204_CR93
  publication-title: J Androl
  doi: 10.2164/jandrol.109.008466
– volume: 12
  start-page: 1857
  issue: 22
  year: 2017
  ident: 204_CR95
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.201700503
– volume: 4
  start-page: e6844
  issue: 8
  year: 2009
  ident: 204_CR109
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0006844
– volume: 158
  start-page: 170
  issue: 1
  year: 2017
  ident: 204_CR50
  publication-title: Endocrinology
  doi: 10.1210/en.2016-1426
– volume-title: Holland-Frei Cancer Medicine
  year: 2003
  ident: 204_CR15
– volume: 11
  start-page: 1134051
  year: 2023
  ident: 204_CR105
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2023.1134051
– volume: 15
  start-page: 465
  issue: 6
  year: 1992
  ident: 204_CR125
  publication-title: Int J Androl
  doi: 10.1111/j.1365-2605.1992.tb01139.x
– volume: 97
  start-page: 3476
  issue: 10
  year: 2012
  ident: 204_CR39
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-1384
– volume: 289
  start-page: 32266
  issue: 46
  year: 2014
  ident: 204_CR112
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.607556
– volume: 4
  start-page: 446
  issue: 5
  year: 2013
  ident: 204_CR79
  publication-title: ACS Med Chem Lett
  doi: 10.1021/ml300365k
– ident: 204_CR55
  doi: 10.3390/pharmacy8030156
– volume: 65
  start-page: 64
  issue: 1
  year: 2020
  ident: 204_CR6
  publication-title: J Midwifery Womens Health
  doi: 10.1111/jmwh.12992
– volume: 3
  start-page: 1
  year: 1961
  ident: 204_CR75
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/0041-008x(61)90002-3
– volume: 7
  start-page: 878
  issue: 6
  year: 2019
  ident: 204_CR38
  publication-title: Andrology
  doi: 10.1111/andr.12603
– volume: 8
  start-page: e1152
  issue: 9
  year: 2020
  ident: 204_CR9
  publication-title: Lancet Glob Health
  doi: 10.1016/s2214-109x(20)30315-6
– volume: 115
  start-page: 1369
  issue: 6
  year: 2021
  ident: 204_CR127
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2021.03.047
– volume: 44
  start-page: 107
  issue: 2
  year: 2012
  ident: 204_CR72
  publication-title: Perspect Sex Reprod Health
  doi: 10.1363/4410712
– volume: 20
  start-page: 549
  issue: 2
  year: 2005
  ident: 204_CR11
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deh574
– volume: 90
  start-page: 407
  issue: 4
  year: 2014
  ident: 204_CR59
  publication-title: Contraception
  doi: 10.1016/j.contraception.2014.05.013
– volume: 106
  start-page: e171
  issue: 1
  year: 2021
  ident: 204_CR67
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaa761
– volume: 14
  start-page: 637
  issue: 1
  year: 2023
  ident: 204_CR103
  publication-title: Nat Commun
  doi: 10.1038/s41467-023-36119-6
– volume: 35
  start-page: 161
  issue: 3
  year: 2009
  ident: 204_CR12
  publication-title: J Fam Plann Reprod Health Care
  doi: 10.1783/147118909788707986
– volume: 273
  start-page: 3509
  issue: 6
  year: 1998
  ident: 204_CR114
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.6.3509
– volume: 150
  start-page: 81
  issue: 1
  year: 2019
  ident: 204_CR119
  publication-title: Indian J Med Res
  doi: 10.4103/ijmr.IJMR_635_18
– volume: 518
  start-page: 110951
  year: 2020
  ident: 204_CR106
  publication-title: Mol Cell Endocrinol
  doi: 10.1016/j.mce.2020.110951
– volume: 93
  start-page: 1774
  issue: 5
  year: 2008
  ident: 204_CR56
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2768
– ident: 204_CR74
  doi: 10.3390/nu14061293
– volume: 82
  start-page: 410
  issue: 5
  year: 2010
  ident: 204_CR51
  publication-title: Contraception
  doi: 10.1016/j.contraception.2010.04.004
– volume: 29
  start-page: 7
  issue: 1
  year: 2022
  ident: 204_CR96
  publication-title: Reprod Sci
  doi: 10.1007/s43032-020-00408-y
– volume: 94
  start-page: 1910
  issue: 6
  year: 2009
  ident: 204_CR33
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-1846
– ident: 204_CR100
  doi: 10.1093/molehr/gaab066
– volume: 175
  start-page: 3144
  issue: 15
  year: 2018
  ident: 204_CR108
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.14355
– volume: 319
  start-page: 211
  issue: 2
  year: 2008
  ident: 204_CR90
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2008.03.047
– ident: 204_CR42
– volume: 120
  start-page: e2221758120
  issue: 8
  year: 2023
  ident: 204_CR113
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2221758120
– volume: 55
  start-page: 1096
  issue: 9
  year: 2018
  ident: 204_CR4
  publication-title: J Sex Res
  doi: 10.1080/00224499.2017.1311834
– volume: 1
  start-page: 899
  issue: 6
  year: 2013
  ident: 204_CR57
  publication-title: Andrology
  doi: 10.1111/j.2047-2927.2013.00135.x
– volume: 100
  start-page: 367
  issue: 5
  year: 2019
  ident: 204_CR1
  publication-title: Contraception
  doi: 10.1016/j.contraception.2019.07.139
– volume: 65
  start-page: 821
  issue: 6
  year: 1996
  ident: 204_CR30
  publication-title: Fertil Steril
  doi: 10.1016/S0015-0282(16)58221-1
– volume: 120
  start-page: 109956
  year: 2023
  ident: 204_CR2
  publication-title: Contraception
  doi: 10.1016/j.contraception.2023.109956
– ident: 204_CR16
  doi: 10.1016/B978-0-323-85718-5.00013-3
– volume: 53
  start-page: 351
  issue: 3
  year: 2000
  ident: 204_CR25
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1046/j.1365-2265.2000.01097.x
– volume: 45
  start-page: 75
  issue: 3
  year: 2022
  ident: 204_CR69
  publication-title: Aust Prescr
  doi: 10.18773/austprescr.2022.025
– volume: 94
  start-page: 2313
  issue: 7
  year: 2009
  ident: 204_CR40
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2008-2604
– volume: 104
  start-page: 43
  issue: Suppl 1
  year: 2014
  ident: 204_CR10
  publication-title: Am J Public Health
  doi: 10.2105/ajph.2013.301416
– volume: 13
  start-page: e0195953
  issue: 4
  year: 2018
  ident: 204_CR99
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0195953
– ident: 204_CR36
– volume: 88
  start-page: 5232
  issue: 11
  year: 2003
  ident: 204_CR17
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-022043
– volume: 25
  start-page: 271
  issue: 2
  year: 2011
  ident: 204_CR13
  publication-title: Best Pract Res Clin Endocrinol Metab
  doi: 10.1016/j.beem.2010.08.006
– volume: 30
  start-page: 126958
  issue: 6
  year: 2020
  ident: 204_CR82
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2020.126958
– volume: 62
  start-page: 73
  issue: 2
  year: 2000
  ident: 204_CR31
  publication-title: Contraception
  doi: 10.1016/S0010-7824(00)00139-6
– volume: 7
  start-page: e1054
  issue: 8
  year: 2019
  ident: 204_CR54
  publication-title: Lancet Glob Health
  doi: 10.1016/s2214-109x(19)30265-7
– volume: 65
  start-page: 10441
  issue: 15
  year: 2022
  ident: 204_CR88
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.2c00453
– volume: 90
  start-page: 2005
  issue: 4
  year: 2005
  ident: 204_CR27
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-1852
– volume: 60
  start-page: 4805
  issue: 12
  year: 2017
  ident: 204_CR85
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.6b01336
– volume: 27
  start-page: 4
  year: 2017
  ident: 204_CR123
  publication-title: Basic Clin Androl
  doi: 10.1186/s12610-017-0048-9
– volume: 56
  start-page: 245
  issue: 4
  year: 1997
  ident: 204_CR118
  publication-title: Contraception
  doi: 10.1016/s0010-7824(97)00142-x
– volume: 105
  start-page: e835
  issue: 3
  year: 2020
  ident: 204_CR47
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgaa032
– volume: 306
  start-page: 1189
  issue: 5699
  year: 2004
  ident: 204_CR98
  publication-title: Science
  doi: 10.1126/science.1099743
– volume: 65
  start-page: 15208
  issue: 22
  year: 2022
  ident: 204_CR102
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.2c01133
– volume: 18
  start-page: 246
  issue: 4
  year: 2017
  ident: 204_CR81
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2016.143
– volume: 28
  start-page: 679
  issue: 5
  year: 2007
  ident: 204_CR18
  publication-title: J Androl
  doi: 10.2164/jandrol.107.002683
– volume: 81
  start-page: 4113
  issue: 11
  year: 1996
  ident: 204_CR24
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.81.11.8923869
– volume: 88
  start-page: 4659
  issue: 10
  year: 2003
  ident: 204_CR23
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2003-030107
– volume: 103
  start-page: 390
  issue: 2
  year: 2020
  ident: 204_CR73
  publication-title: Biol Reprod
  doi: 10.1093/biolre/ioaa122
– volume: 12
  start-page: 838
  issue: 10
  year: 2016
  ident: 204_CR104
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.2151
– volume: 32
  start-page: 111
  issue: 1
  year: 2011
  ident: 204_CR78
  publication-title: J Androl
  doi: 10.2164/jandrol.110.010751
– volume: 13
  start-page: 891589
  year: 2022
  ident: 204_CR3
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2022.891589
– volume: 32
  start-page: 183
  issue: 2
  year: 2011
  ident: 204_CR65
  publication-title: J Androl
  doi: 10.2164/jandrol.110.010371
– volume: 17
  start-page: e202000499
  issue: 15
  year: 2022
  ident: 204_CR111
  publication-title: ChemMedChem
  doi: 10.1002/cmdc.202000499
– volume: 148
  start-page: 1784
  issue: 4
  year: 2007
  ident: 204_CR64
  publication-title: Endocrinology
  doi: 10.1210/en.2006-1487
– volume: 106
  start-page: e2381
  issue: 6
  year: 2021
  ident: 204_CR128
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/clinem/dgab034
– volume: 3
  start-page: 11
  year: 2022
  ident: 204_CR120
  publication-title: J Reprod Healthc Med
  doi: 10.25259/JRHM_8_2022
– volume: 108
  start-page: 5879
  issue: 14
  year: 2011
  ident: 204_CR116
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1100240108
– volume: 336
  start-page: 955
  issue: 8721
  year: 1990
  ident: 204_CR29
  publication-title: Lancet
  doi: 10.1016/0140-6736(90)92416-F
– volume: 18
  start-page: 607
  issue: 6
  year: 1978
  ident: 204_CR35
  publication-title: Contraception
  doi: 10.1016/0010-7824(78)90045-8
– volume: 76
  start-page: 432
  issue: 6
  year: 2007
  ident: 204_CR52
  publication-title: Contraception
  doi: 10.1016/j.contraception.2007.08.006
– volume: 92
  start-page: 1141
  issue: 3
  year: 2009
  ident: 204_CR107
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2008.07.1751
– ident: 204_CR53
– ident: 204_CR87
  doi: 10.1073/pnas.2021102118
– volume: 17
  start-page: 263349412211383
  year: 2023
  ident: 204_CR129
  publication-title: Ther Adv Reprod Health
  doi: 10.1177/26334941221138323
– volume: 77
  start-page: 52
  issue: 1
  year: 2020
  ident: 204_CR70
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2019.2838
– volume: 2
  start-page: 579
  issue: 4
  year: 2014
  ident: 204_CR45
  publication-title: Andrology
  doi: 10.1111/j.2047-2927.2014.00216.x
– volume: 120
  start-page: e2212338120
  issue: 4
  year: 2023
  ident: 204_CR117
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2212338120
– volume: 152
  start-page: 2492
  issue: 6
  year: 2011
  ident: 204_CR76
  publication-title: Endocrinology
  doi: 10.1210/en.2010-0941
– volume: 77
  start-page: 427
  issue: 2
  year: 1993
  ident: 204_CR21
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.77.2.8345047
– volume: 150
  start-page: 673
  issue: 4
  year: 2012
  ident: 204_CR84
  publication-title: Cell
  doi: 10.1016/j.cell.2012.06.045
– volume: 103
  start-page: 264
  issue: 2
  year: 2020
  ident: 204_CR89
  publication-title: Biol Reprod
  doi: 10.1093/biolre/ioaa064
– volume: 87
  start-page: 530
  issue: 2
  year: 2002
  ident: 204_CR26
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem.87.2.8218
– volume: 122
  start-page: 212
  issue: 4
  year: 2010
  ident: 204_CR68
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2010.06.009
– volume: 18
  start-page: 609
  issue: 8
  year: 2019
  ident: 204_CR80
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-019-0030-7
– volume: 27
  start-page: 8
  year: 2017
  ident: 204_CR122
  publication-title: Basic Clin Androl
  doi: 10.1186/s12610-017-0051-1
– volume: 134
  start-page: 3507
  issue: 19
  year: 2007
  ident: 204_CR83
  publication-title: Development
  doi: 10.1242/dev.004481
– volume: 104
  start-page: 423
  issue: 2
  year: 2019
  ident: 204_CR43
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-01452
– ident: 204_CR101
  doi: 10.1093/molehr/gaab054
– volume: 61
  start-page: 4317
  issue: 10
  year: 2018
  ident: 204_CR86
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.7b01666
– volume: 104
  start-page: 629
  issue: 3
  year: 2019
  ident: 204_CR48
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2018-01528
– ident: 204_CR58
– volume: 65
  start-page: 629
  issue: 10–11
  year: 2000
  ident: 204_CR49
  publication-title: Steroids
  doi: 10.1016/s0039-128x(00)00119-7
– volume: 73
  start-page: 1360
  issue: 6
  year: 1991
  ident: 204_CR20
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-73-6-1360
– volume: 15
  start-page: 672
  issue: 3
  year: 2000
  ident: 204_CR22
  publication-title: Hum Reprod
  doi: 10.1093/humrep/15.3.672
– volume: 25
  start-page: 4250
  issue: 10
  year: 2005
  ident: 204_CR92
  publication-title: Mol Cell Biol
  doi: 10.1128/mcb.25.10.4250-4261.2005
– volume: 143
  start-page: 211
  issue: 2
  year: 2012
  ident: 204_CR19
  publication-title: Reproduction
  doi: 10.1530/rep-11-0171
– volume: 26
  start-page: 6
  year: 2016
  ident: 204_CR121
  publication-title: Basic Clin Androl
  doi: 10.1186/s12610-016-0033-8
SSID ssj0000993080
Score 2.3145328
SecondaryResourceType review_article
Snippet BackgroundSince the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60...
Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning. Over 60 years later,...
Abstract Background Since the release of the combined oral contraceptive pill in 1960, women have shouldered the burden of contraception and family planning....
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Androgens
Birth control
Clinical trials
Endocrinology
Estrogens
Hormones
Male contraception
Males
Progestin
R&D
Reproductive health
Research & development
Review
Sperm
Spermatogenesis
Vasectomy
Womens health
SummonAdditionalLinks – databaseName: Health & Medical Collection (ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELYoXLhUbSnqAq1cCfVSWcSx4zhcKloVoUpwKtLeLD_GUKlNYHc5lF_P2PFumwtSTrHz0HjG8814HoQchwZ0G1G-g28Uk6GtmOXeMgcgQs2jrmXKRr68UhfX8se8mReH27KEVa73xLxRh8EnH_lJOhCrVI0I-svdPUtdo9Lpammh8YLspNJlKaSrnbcbHwuiH4GIaJ0ro9XJkqPFUDFUVCynhbLHiT7KZfsnWHMaKfmf6jl_RV4WzEjPxkV-Tbagf0P2znq0l__8pZ9ojuLM7vE9oi9xx6c5AN2WiJVT2tvFWOCbjpkqdIh06G8GVFu0VPu5fUuuz7___HbBSncE5hvJVyxo26IC99BIxytrHfIEh2BlUwdXewFB-qpzqAQhOhm5tgGhg2yFAl8L6MQ-2e6HHt4R2iEqAVW3UeJlcWrjEJfgQimhbLBuRviaRsaX0uGpg8Vvk00IrcxIV4N0NZmu5nFGPm-euRsLZzw7-2si_WZmKnqdbwyLG1NkyPAYOXCvHRpdUjYRmaxDKgDvwPkg1IwcrRfOFElcmn98MyMfN8MoQ-lgxPYwPKQ5uIshEuX4Cj1Z8MkPTUf6X7e5Gjfa1AKNcH7w_NcPyW7qVJ_TGLsjsr1aPMB7xDMr9yEz7RP2cfaq
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEB9qe-lF1Lb4tMoK4kW2ZrObzUYQacVSCs-TD3pb9rO11ERfX8H2r3d2kzwaKJ6EnJLZkMxH5jfZ-QB466ug6oj27V0lqfB1QQ1zhtoQuC9ZVKVI1cjzb_JkIU7PqrMNGMcdDQy8fjC0S_OkFsurgz-_bz-jwX_KBq_kh2uGYUBB0fvQXOtJ7x7BFnqmOhnqfID7lz0a4oiQxtqZB5dO_FNu4z_BntPMyXuu6PgJPB4wJDnshf4UNkL7DHYOW4yff96SdyRndebf5Tug5ugBSE5IN0MGy0fSmmXf8Jv0lSuki6Rrzzt0Y2To_nOxC4vjr9-_nNBhWgJ1lWAr6pWp0aG7UAnLCmMs6ggL3oiq9LZ0PHjhisaiUwzRisiU8QglRM1lcCUPDd-DzbZrw3MgDaKUIMs6CjwMklYWcQoKTnJpvLEzYCOPtBtaiaeJFlc6hxRK6p6vGvmqM1_13Qzer9f86htp_JP6KLF-TZmaYOcT3fJcDzalWYwsMKcsBmFCVBGVrkEuBNYE6zyXM9gfBadHxdJpY7WQJUZiM3izvow2lTZKTBu6m0SDXzVEpgxvoSYCnzzQ9Er74yJ358YYm2NQzl78j1d4Cdtpvn0ufmz2YXO1vAmvEAWt7Ous2n8BCrIHmQ
  priority: 102
  providerName: Scholars Portal
Title Male contraception: narrative review of ongoing research
URI https://www.proquest.com/docview/2890062217
https://www.proquest.com/docview/2888035216
https://pubmed.ncbi.nlm.nih.gov/PMC10634021
https://doaj.org/article/1ff1e1c8b606445f87f9d8ae19ebcd36
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB1RuHCpChR1Kaxcqeqlsohjx3F6gwqEkBZVVZH2ZvmztIKkguVQfn3HTna1uZQLUpRD7ET2eOx5E888A3z0VVB1xPntXSWp8HVBDXOG2hC4L1lUpUjZyLMreXEtLufVfO2orxQT1tMD94I7ZjGywJyyiLSFqCJ-ufHKBNYE6zzPZNto89acqd897uGIhZZZMkoePzD0FQqKJormhFD6NLJEmbB_hDLHMZJrRuf8Dbwe0CI56Vu5Axuh3YW9kxY95bu_5BPJ8Zv5x_geqBmu9SSHnpshVuULac19T-1N-hwV0kXStT87NFhk4Pm5eQvX52c_vl7Q4VwE6irBFhS7X6PpdqESlhXGWNQGFrwRVelt6XjwwhWNRfMXohWRKeMRNIiay-BKHhq-D5tt14Z3QBrEI0GWdRR4GaxaWUQkOESSS-ONnQBbyki7gTQ8nV1xq7PzoKTu5apRrjrLVT9N4PPqnT89ZcZ_a58m0a9qJrrr_ACVQA9KoJ9TggkcLgdOD3PwQact1EKW6HNN4MOqGGdP2hIxbegeUx1cvxCDMvyEGg34qEHjkvbXTebhRm-ao_vNDl6iC-9hO51kn9Mcm0PYXNw_hiPEOws7hVf1vJ7C1unZ1bfv06zoeJ8J9Q_spwOR
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5V2wNcEFAQWwoYCbggq7HjOAkSQi202tLuCqFW6s34lRYJkrK7FWp_FL-RsZMs5NJbpZxi56HxjOeb8TwAXrnMF3mF8u1sJqlweUI1s5oa71PHWVVwEbKRpzM5ORGfT7PTNfjT58KEsMp-T4wbtWts8JFvhwOxRHJE0B8uftHQNSqcrvYtNFq2OPRXv9FkW7w_-ITr-5rz_b3jjxPadRWgNhNsSV2hc1R81mfCsERrg7Rk3mmRcWe4Tb0TNikNKg9fGVGxQjtUuSJPpbc89aH4Em756yJFU2YE67t7sy9fV14dxFspYrA-O6eQ2wuGNkpCUTXSmIhKrwcaMDYKGKDbYWzmf8pu_z7c61Aq2WnZ6gGs-fohbOzUaKH_vCJvSIwbjQ75DSimqGNIDHnXXYzMO1LreVtSnLS5MaSpSFOfNagoSVdf6PwRnNwK5R7DqG5q_wRIiTjIS55XAi-NUzODSAhZQ6ZSO23GwHoaKdsVKw89M36oaLQUUrV0VUhXFemqrsfwdvXMRVuq48bZu4H0q5mhzHa80czPVCe1ilUV88wWBs08IbIK2bpEKnhWemNdKsew1S-c6mR_of5x6hheroZRasNRjK59cxnm4L6J2JfhK4rBgg9-aDhSfz-P9b_Rik_R7GebN3_9BdyZHE-P1NHB7PAp3OWBBYM_vNyC0XJ-6Z8hmlqa5x0LE_h221LzFwCIN-g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Male+contraception%3A+narrative+review+of+ongoing+research&rft.jtitle=Basic+and+clinical+andrology&rft.au=Eli+J.+Louwagie&rft.au=Garrett+F.L.+Quinn&rft.au=Kristi+L.+Pond&rft.au=Keith+A.+Hansen&rft.date=2023-11-09&rft.pub=BMC&rft.eissn=2051-4190&rft.volume=33&rft.issue=1&rft.spage=1&rft.epage=12&rft_id=info:doi/10.1186%2Fs12610-023-00204-z&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1ff1e1c8b606445f87f9d8ae19ebcd36
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-4190&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-4190&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-4190&client=summon